PhRMA says companies implementing principles

Share this article:
An initial report by the Pharmaceutical Research and Manufacturers of America (PhRMA) Office of Accountability says that all companies that have signed the group's "Guiding Principles on Direct to Consumer Advertisements About Prescription Medicines" say they have put in internal procedures to implement the principles.

The report says examples of the PhRMA members' internal procedures include establishing multidisciplinary teams of personnel to review print and TV ads to ensure compliance with FDA regulations and the PhRMA principles; modifying internal guidelines for advertising, and establishing standard operating procedures to collect and respond to comments received on ads.
Most companies reported alerting advertising and media professionals with whom they work about the principles. This included giving vendors copies of the principles, providing training on them and ensuring they are considered when new ads are developed.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...